Advertisement

Clinical Rheumatology

, Volume 32, Issue 6, pp 829–837 | Cite as

Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases

  • Chan Hee Lee
  • Na Young Sung
  • Jisoo Lee
  • Sang-Cheol Bae
Original Article

Abstract

The aim of this study was to identify the factors associated with gout among South Koreans. A case control study of gout patients newly diagnosed between January 1, 2007, and December 31, 2008, and matching controls was conducted using the nationwide database (National Health Insurance Corporation and National Health Screening Exam (NHSE) database), which included the health-care records of 48.1 million individuals. Of 495,998 newly diagnosed patients, we included 18,123 who were ≥40 years old and had an NHSE before diagnosis of gout. To elucidate the factors associated with gout, multivariate conditional logistic analyses were performed. Gout was associated with drinking ≥1/week (p < 0.001), drinking ≥1 bottle of soju/session (p < 0.001), high body mass index (BMI) (p < 0.001), high blood pressure (p < 0.001), high total cholesterol (p < 0.001), proteinuria (multivariate odds ratio (OR) = 1.75; 95 % confidence interval (CI) = 1.53–2.00), and an elevated uric acid (multivariate OR = 1.54; 95 % CI = 1.22–1.94). Exercise frequency was not significantly associated with gout. Prediabetic blood sugar level (100–125 mg/dL) was associated with gout in the univariate analysis, but not in the multivariate analysis. Diabetic blood sugar level (≥126 mg/dL) was associated with a decreased odds of gout (multivariate OR = 0.79; 95 % CI = 0.73–0.86). Our nationwide South Korean study showed that frequent and excessive alcohol consumption, high BMI, high blood pressure, high total cholesterol, proteinuria, and high uric acid are associated with gout.

Keywords

Factors Gout Nationwide database South Koreans 

Notes

Acknowledgments

This study was supported by NHIC Ilsan Hospital Clinical Research Grant. We would like to give special thanks to the NHIC for allowing us to use NHIC and NHSE databases.

Disclosures

None.

References

  1. 1.
    Yoo HG, Lee SI, Chae HJ, Park SJ, Lee YC, Yoo WH (2011) Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol Int 31:485–491PubMedCrossRefGoogle Scholar
  2. 2.
    Choi HK (2010) A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 22:165–172PubMedCrossRefGoogle Scholar
  3. 3.
    Novak S, Melkonian AK, Patel PA, Kleinman NL, Joseph-Ridge N, Brook RA (2007) Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use. Curr Med Res Opin 23:623–630PubMedCrossRefGoogle Scholar
  4. 4.
    Perez-Ruiz F, Calabozo M, Herrero-Beites AM, Garcia-Erauskin G, Pijoan JI (2000) Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 86:287–291PubMedCrossRefGoogle Scholar
  5. 5.
    Shah A, Keenan RT (2010) Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? Curr Rheumatol Rep 12:118–124PubMedCrossRefGoogle Scholar
  6. 6.
    Gaffo AL, Edwards NL, Saag KG (2009) Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther 11:240PubMedCrossRefGoogle Scholar
  7. 7.
    Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403–2406PubMedGoogle Scholar
  8. 8.
    Currie WJ (1979) Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 38:101–106PubMedCrossRefGoogle Scholar
  9. 9.
    Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis 64:267–272PubMedCrossRefGoogle Scholar
  10. 10.
    Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26–35PubMedCrossRefGoogle Scholar
  11. 11.
    Annemans L, Spaepen E, Gaskin M et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966PubMedCrossRefGoogle Scholar
  12. 12.
    Lee CH, Sung NY (2011) The prevalence and features of Korean gout patients using the National Health Insurance Corporation Database. J Korean Rheum Assoc 18:94–100Google Scholar
  13. 13.
    Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57:109–115PubMedCrossRefGoogle Scholar
  14. 14.
    Chang HY, Pan WH, Yeh WT, Tsai KS (2001) Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–96). J Rheumatol 28:1640–1646PubMedGoogle Scholar
  15. 15.
    Rho YH, Choi SJ, Lee YH et al (2005) The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 20:1029–1033PubMedCrossRefGoogle Scholar
  16. 16.
    Chung HG, Song JS (2009) 2008 National Health Insurance statistical yearbook. National Health Insurance Corporation, Health Insurance Review & Assessment Service, SeoulGoogle Scholar
  17. 17.
    Korean Society for the Study of Obesity (2009) Obesity treatment guideline, 2009. Chungun Publisher, SeoulGoogle Scholar
  18. 18.
    Expert Consultation WHO (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRefGoogle Scholar
  19. 19.
    Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560–2572PubMedCrossRefGoogle Scholar
  20. 20.
    American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30:S42–S47CrossRefGoogle Scholar
  21. 21.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRefGoogle Scholar
  22. 22.
    Choi HK, Curhan G (2004) Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 51:1023–1029PubMedCrossRefGoogle Scholar
  23. 23.
    Gaffo AL, Roseman JM, Jacobs DR Jr et al (2010) Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis 69:1965–1970PubMedCrossRefGoogle Scholar
  24. 24.
    Koh MJ, Han JT, Lee AK, Kim MK, Park SH (2008) Construction of national health screening examinee cohort—development of the validity test. National Health Insurance Corporation, SeoulGoogle Scholar
  25. 25.
    Park IS, Koh MJ, Kim HJ (2009) Construction of national health screening examinee cohort—validity test of National Health Insurance Database (II). National Health Insurance Corporation, SeoulGoogle Scholar
  26. 26.
    Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, 3rd Miller ER (2005) Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 165:2299–2304PubMedCrossRefGoogle Scholar
  27. 27.
    Lim S, Park KS, Lee HK, Cho SI, Health KN, Surveys NE (2005) Changes in the characteristics of metabolic syndrome in Korea over the period 1998–2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 28:1810–1812PubMedCrossRefGoogle Scholar
  28. 28.
    Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363:1277–1281PubMedCrossRefGoogle Scholar
  29. 29.
    Choi HK, Ford ES (2007) Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120:442–447PubMedCrossRefGoogle Scholar
  30. 30.
    Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165:742–748PubMedCrossRefGoogle Scholar
  31. 31.
    Kuo CF, See LC, Luo SF et al (2010) Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatol (Oxford) 49:141–146CrossRefGoogle Scholar
  32. 32.
    Williams PT (2008) Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 87:1480–1487PubMedGoogle Scholar
  33. 33.
    Zhu Y, Zhang Y, Choi HK (2010) The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatol (Oxford) 49:2391–2399CrossRefGoogle Scholar
  34. 34.
    Nan H, Qiao Q, Soderberg S et al (2008) Serum uric acid and incident diabetes in Mauritian Indian and Creole populations. Diabetes Res Clin Pract 80:321–327PubMedCrossRefGoogle Scholar
  35. 35.
    Rodriguez G, Soriano LC, Choi HK (2010) Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 69:2090–2094PubMedCrossRefGoogle Scholar
  36. 36.
    Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006PubMedCrossRefGoogle Scholar
  37. 37.
    Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels—the Third National Health and Nutrition Examination Survey. Rheumatol (Oxford) 47:713–717CrossRefGoogle Scholar
  38. 38.
    Jo SY, Park Y, Lee CH (2011) The effect of hypouricemic treatment on the renal function in patients with gout. J Korean Rheum Assoc 18:26–31Google Scholar
  39. 39.
    Kondo M, Yamagata K, Hoshi SL et al (2012) Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol 16:279–291PubMedCrossRefGoogle Scholar
  40. 40.
    Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y (2006) Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 33:104–109PubMedGoogle Scholar
  41. 41.
    McAdams MA, Maynard JW, Baer AN et al (2011) Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 38:135–141PubMedCrossRefGoogle Scholar
  42. 42.
    Park SK, Cheong HK, Ki M, Son YM, Kim H (2003) Assessment of the availability of health insurance data for epidemiologic study of childhood aseptic meningitis. Korean J Prev Med 36:349–358Google Scholar
  43. 43.
    Cheong HK, Park SK, Ki M, Lee K (2008) Six year national trend of childhood aseptic meningitis incidence in Korea, 1996–2001. Korean J Epidemiol 30:252–262CrossRefGoogle Scholar
  44. 44.
    Kim J (2008) Diabetes in Korea 2007. In: Korean Diabetes Association, Health Insurance Review & Assessment Service, Task Force Team For Basic Statistical Study of Korean Diabetes Mellitus (ed) Validity of health insurance data, Firstth edn. Goldfishery, Seoul, pp 7–13Google Scholar
  45. 45.
    Park BJ, Sung JH, Park KD, Seo SW, Kim SW (2003) Report of the evaluation for validity of discharged diagnoses in Korean Health Insurance Database. Seoul National University, SeoulGoogle Scholar

Copyright information

© Clinical Rheumatology 2013

Authors and Affiliations

  • Chan Hee Lee
    • 1
  • Na Young Sung
    • 2
    • 3
    • 4
  • Jisoo Lee
    • 5
  • Sang-Cheol Bae
    • 6
  1. 1.Division of Rheumatology, Department of Internal MedicineNational Health Insurance Corporation Ilsan HospitalGoyang-siSouth Korea
  2. 2.Institute of Health Insurance and Clinical ResearchNational Health Insurance Corporation Ilsan HospitalGoyang-siSouth Korea
  3. 3.Cancer Early Detection BranchNational Cancer CenterGoyang-siSouth Korea
  4. 4.Department of Biostatistics and ComputingYonsei UniversitySeoulSouth Korea
  5. 5.Division of Rheumatology, Department of Internal MedicineEwha Womans University School of MedicineSeoulSouth Korea
  6. 6.Department of RheumatologyHanyang University Hospital for Rheumatic DiseasesSeoulSouth Korea

Personalised recommendations